From author Kanak Kanti De: Article is ready. Waiting to talk to Missling who agreed to after AAIC. Theoretically better science then plaque reducing agents. Think they will get the patent and reach some sort of a deal with Dr V. If p 2a is successful, good chance of a buyout.